GGP06181/TI_/Telethon/Italy[Grants and Funding] - Search Results

Year	Number of Results
2007	3
2008	3
2009	5
2010	1
2024	0

1

DNA instability in replicating Huntington's disease lymphoblasts.

Cannella M, Maglione V, Martino T, Ragona G, Frati L, Li GM, Squitieri F. Cannella M, et al. BMC Med Genet. 2009 Feb 11;10:11. doi: 10.1186/1471-2350-10-11. BMC Med Genet. 2009. PMID: 19210789 Free PMC article.

2

Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients.

Ciammola A, Sassone J, Cannella M, Calza S, Poletti B, Frati L, Squitieri F, Silani V. Ciammola A, et al. Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):574-7. doi: 10.1002/ajmg.b.30501. Am J Med Genet B Neuropsychiatr Genet. 2007. PMID: 17427191

3

Abnormal morphology of peripheral cell tissues from patients with Huntington disease.

Squitieri F, Falleni A, Cannella M, Orobello S, Fulceri F, Lenzi P, Fornai F. Squitieri F, et al. J Neural Transm (Vienna). 2010 Jan;117(1):77-83. doi: 10.1007/s00702-009-0328-4. Epub 2009 Oct 16. J Neural Transm (Vienna). 2010. PMID: 19834779

4

Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins.

Squitieri F, Orobello S, Cannella M, Martino T, Romanelli P, Giovacchini G, Frati L, Mansi L, Ciarmiello A. Squitieri F, et al. Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1113-20. doi: 10.1007/s00259-009-1103-3. Epub 2009 Mar 11. Eur J Nucl Med Mol Imaging. 2009. PMID: 19280185 Clinical Trial.

5

Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts.

Liquori CL, Penco S, Gault J, Leedom TP, Tassi L, Esposito T, Awad IA, Frati L, Johnson EW, Squitieri F, Marchuk DA, Gianfrancesco F. Liquori CL, et al. Neurogenetics. 2008 Feb;9(1):25-31. doi: 10.1007/s10048-007-0109-x. Epub 2007 Dec 1. Neurogenetics. 2008. PMID: 18060436

6

Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease.

Squitieri F, Cannella M, Simonelli M, Sassone J, Martino T, Venditti E, Ciammola A, Colonnese C, Frati L, Ciarmiello A. Squitieri F, et al. CNS Neurosci Ther. 2009 Winter;15(1):1-11. doi: 10.1111/j.1755-5949.2008.00068.x. CNS Neurosci Ther. 2009. PMID: 19228174 Free PMC article.

7

Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy?

Herishanu YO, Parvari R, Pollack Y, Shelef I, Marom B, Martino T, Cannella M, Squitieri F. Herishanu YO, et al. J Neurol Sci. 2009 Feb 15;277(1-2):143-6. doi: 10.1016/j.jns.2008.11.005. Epub 2008 Dec 6. J Neurol Sci. 2009. PMID: 19059613

8

Neuroprotective effects of riluzole in Huntington's disease.

Squitieri F, Ciammola A, Colonnese C, Ciarmiello A. Squitieri F, et al. Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):221-2. doi: 10.1007/s00259-007-0615-y. Epub 2007 Nov 6. Eur J Nucl Med Mol Imaging. 2008. PMID: 17987289 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year